Abstract:Ezrin is known to regulate cellular survival, adhesion, migration, and invasion and has been identified as 1 of the key components of tumor progression and metastasis. The purpose of this study was to evaluate the clinicopathologic and prognostic significance of ezrin expression in non-small-cell lung cancer (NSCLC).We investigated the expression pattern of ezrin immunohistochemically in 89 paraffin samples of NSCLC between January 1998 and December 2006 and conducted survival analyses. In addition, 73 frozen specimens (including tumorous and precancerous tissues) of NSCLC and 28 frozen specimens of benign pneumonic diseases collected between January 2009 and December 2009 were analyzed by Western blot and reverse transcriptase-polymerase chain reaction (RT-PCR).In 89 paraffin samples, ezrin was expressed in 40 cases, either in the cytoplasm or on the membrane. Ezrin-positive expression was significantly associated with increased tumor stage and lymph node (LN) metastasis. The positive rate of cytoplasm expression was significantly associated with LN metastasis. Importantly, ezrin-positive expression independently predicted inferior overall survival (OS) and disease-free survival (DFS). In 73 frozen specimens of NSCLC and 28 frozen specimens of benign pneumonic diseases, the ezrin mRNA, protein, and phospho-ezrin protein expressions in tumorous tissues were higher than they were in precancerous tissues and benign pneumonic tissues.These results suggested that high-level ezrin expression contributed to NSCLC progression and that phosphorylation and subcellular translocation of ezrin might be the important mechanisms. Ezrin might be a potential prognostic marker of progression in NSCLC.

Expression and Significance of FRA-1 in Non-Small-cell Lung Cancer.

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis

FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy

Expression and function of FRA1 protein in tumors

Abnormal Expression and Clinical Significance of Telomeric Repeat Binding Factor 1 and Tankyrase 1 in Non-small Cell Lung Cancer

An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy

Fra-1 Promotes Breast Cancer Chemosensitivity By Driving Cancer Stem Cells From Dormancy

Data from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Expression and clinical significance of ezrin in non--small-cell lung cancer.

The expression of human antigen R and vascular endothelial growth factor-C and their significance in non-small cell lung cancer]

Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.

Expression of FAP-1 Protein in Lung Cancer and Its Clinical Implication

Fra-1 is Upregulated in Gastric Cancer Tissues and Affects the PI3K/Akt and P53 Signaling Pathway in Gastric Cancer

TNF Receptor-Associated Factor 1 As a Biomarker for Assessment of Non-Small Cell Lung Cancer Metastasis and Overall Survival

Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway

Expression of Long Non-Coding RNA SFTA1P and Its Function in Non-Small Cell Lung Cancer

Clinical significance of the expression of alpha-fetoprotein receptor in human non small cell lung cancer

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

Expression and Significance of Flk-1, LRP in Non-small Cell Lung Carcinoma

Expression of Fas/Fasl Gene Protein and Its Chinical Significance in Human Non-small Cell Lung Cancer